Jeremy Segal to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Jeremy Segal has written about Xenograft Model Antitumor Assays.
Connection Strength
0.032
-
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy. Clin Cancer Res. 2017 Aug 01; 23(15):4212-4223.
Score: 0.032
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.